Table 1.
Distribution of patients and clinical parameters in the Swedish and Norwegian data sets
Click on table to view larger version.
Numbers will not add up exactly because of partial information on certain individual cases.
aProgesterone (PR) and estrogen (ER) receptors measured by ligand binding; (pos) ≥0.5 fg/μg protein.
bERBB2 amplification scored by ROMA as segmented ratio >0.1 above baseline.
